The European Commission granted an approval under exceptional circumstances to InflaRx’s immunosuppressant. The European ...

San Francisco’s public health director, who oversaw the city’s responses to the COVID-19 pandemic and fentanyl crisis, ...

Six-month outcomes of children and adolescents diagnosed with multisystem inflammatory syndrome in children (MIS-C) after ...

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant ...

Human metapneumovirus (hMPV) is one of the viruses that causes the common cold. It usually makes people only mildly poorly, ...

Starmer’s Labour government is risking patient safety by shifting burdens instead of solving systemic issues. Though he ...

The latest round of the COVID inquiry focuses on vaccines and anti-viral treatment across the UK. Today we're hearing ...

Sustained funding is needed for screening and care, but industry must also shoulder costs Alcohol is widely available and drunk by around 80% of adults in the UK. No safe level of alcohol consumption ...

Patients are dying in “horror film” hospital corridors so crowded that nurses cannot reach them, a bombshell report reveals ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with ...